Indications and Outcomes of Intravitreal Triamcinolone Acetonide Injection in Macular Oedema

Abstract

To determine the indications, complications, and outcomes of intravitreal triamcinolone acetonide (IVitTA) injection in macular oedema. METHODSThis retrospective study included 105 eyes of 81 patients who received 4 mg IVitTA for treatment of macular oedema due to different aetiologies between May 2011-October 2012. Recorded were demographic data, best corrected visual acuity, intraocular pressure (IOP), degree of cataract if any, macular thickness (By optical coherence tomography) complications and improvement in visual acuity and macular oedema. RESULTSShort-term improvement in visual acuity and macular thickness were in 50% patients and long-term outcomes were less promising. Main complications were cataract (61%), increase in IOP (31%). CONCLUSIONIVitTA remains a promising therapy for patients with macular oedema of different aetiologies refractory to other modalities of treatment at least in short term. It seems relatively safe, but not without complications.